RT @ericdeinmd: How is a biosimilar approved? Comparative effectiveness study for the reason that the medication was ini

Social Author Image
https://pbs.twimg.com/profile_images/1322922848810422289/oM4qP9_k.jpg
Tweet Author
ericdeinmd
Social Author Name
Eric Dein
Tweet Content
How is a biosimilar approved? Comparative effectiveness study for the reason that the medication was initial approved required, not for other indications Jonathan Kay shows ex of ETN-ykro vs reference ETN in RA Non-inferior in immunogenicity, safety, efficacy @RheumNow #RNL2023 https://t.co/OOHie9Qr5t

RT @ericdeinmd: Great #RNL2023 Plenary with "Miracle Larry" after 128 days in hospital for COVID-19, on 3-year anniversa

Social Author Image
https://pbs.twimg.com/profile_images/1322922848810422289/oM4qP9_k.jpg
Tweet Author
ericdeinmd
Social Author Name
Eric Dein
Tweet Content
Great #RNL2023 Plenary with "Miracle Larry" after 128 days in hospital for COVID-19, on 3-year anniversary of going into coma "I am the expert on what this virus can do. I don't want the world to ever forget" @RheumNow https://t.co/kTuDXDhTtQ

RT @doctorRBC: Tremendously emotional (and unfiltered) first person account of his fight with COVID-19 by Miracle Larry

Social Author Image
https://pbs.twimg.com/profile_images/1324821320429981703/dAiq_hpT.jpg
Tweet Author
doctorRBC
Social Author Name
Robert B Chao, MD
Tweet Content
Tremendously emotional (and unfiltered) first person account of his fight with COVID-19 by Miracle Larry who thanked our Dr. Cush @RheumNow for his ingenuity in fighting COVID-19, thanking healthcare workers for all they do, and reminding us to be empathic. #RNL2023 https://t.co/i0D7r8dR8n

RT @ericdeinmd: Was amazed at the tons of biosimilar TNF options @_connectedcare uses in Australia... coming soon to the

Social Author Image
https://pbs.twimg.com/profile_images/1322922848810422289/oM4qP9_k.jpg
Tweet Author
ericdeinmd
Social Author Name
Eric Dein
Tweet Content
Was amazed at the tons of biosimilar TNF options @_connectedcare uses in Australia... coming soon to the US! Jonathan Kay #RNL2022 shows the lists of biosimilar May be w/in batch-to-batch variability, unintended drift, or deliberate process changes (evolution) @RheumNow https://t.co/sfVQspxbyr

RT @ericdeinmd: Jonathan Kay on #RNL2023: Biosimilar is well-researched with cost savings These savings should benefit t

Social Author Image
https://pbs.twimg.com/profile_images/1322922848810422289/oM4qP9_k.jpg
Tweet Author
ericdeinmd
Social Author Name
Eric Dein
Tweet Content
Jonathan Kay on #RNL2023: Biosimilar is well-researched with cost savings These savings should benefit the patients Incentives for physicians as well in form of decreased prior auth burdens @RheumNow

RT @uptoTate: RBC MTX polyglutamate levels may be the “truth serum” for those pts stating they are taking their MTX

Social Author Image
https://pbs.twimg.com/profile_images/847812732007133184/hIbnEHt3.jpg
Tweet Author
uptoTate
Social Author Name
Dr. Rachel Tate
Tweet Content
RBC MTX polyglutamate levels may be the “truth serum” for those pts stating they are taking their MTX but you question it. Dr. Kremer @RheumNow #RNL2023

RT @ericdeinmd: Great #RNL22 Plenary with "Miracle Larry" after 128 days in hospital for COVID-19, on 3-year anniversary

Social Author Image
https://pbs.twimg.com/profile_images/1322922848810422289/oM4qP9_k.jpg
Tweet Author
ericdeinmd
Social Author Name
Eric Dein
Tweet Content
Great #RNL22 Plenary with "Miracle Larry" after 128 days in hospital for COVID-19, on 3-year anniversary of going into coma "I am the expert on what this virus can do. I don't want the world to ever forget" @RheumNow https://t.co/6zgRwzOwz4
Subscribe to
How well do you know this week's rheumatology news?
Take the rheumIQ quiz
Take the RheumIQ Quiz

×